Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
sotatercept
MeSH Supplementary Concept Data 2025
Details
Concepts
MeSH Supplementary
sotatercept
Unique ID
C542017
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C542017
Entry Term(s)
ACE-011
winrevair
Registry Numbers
0QI90BTJ37
Heading Mapped to
*Recombinant Fusion Proteins
Frequency
36
Note
a dimeric fusion protein consisting of the extracellular domain of the human ActRIIA linked to the Fc portion of human IgG1. On March 26, 2024, FDA-approved sotatercept for the treatment of pulmonary arterial hypertension (PAH).
Source
J Bone Miner Res 2009 Apr;24(4):744-52
Indexing Information
Immunoglobulin G
Date of Entry
2025/03/10
Revision Date
2025/03/07
Expand All
Collapse All
sotatercept
Preferred
Concept UI
M0537365
Registry Numbers
0QI90BTJ37
Terms
sotatercept
Preferred Term
Term UI
T842806
Date
04/18/2013
LexicalTag
NON
ThesaurusID
NLM (2013)
ACE-011
Narrower
Concept UI
M000768807
Terms
ACE-011
Preferred Term
Term UI
T754436
Date
07/14/2009
LexicalTag
LAB
ThesaurusID
NLM (2009)
winrevair
Narrower
Concept UI
M000768808
Terms
winrevair
Preferred Term
Term UI
T001147329
Date
03/07/2025
LexicalTag
TRD
ThesaurusID
NLM (2025)
page delivered in 0.004s